Drug Trial Radar · NCT07918859
A Study of Imlunestrant (LY3484356) in Healthy Female Participants
Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
343
Planned (sponsor's estimate)
Start
Nov 2026
Primary completion
Aug 2027
Study completion Aug 2027
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Nov 5, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The main purpose of this study is to measure the amount of imlunestrant that gets into the bloodstream and how long it takes the body to get rid of it when given in two different formulations. This study also compares the two different formulations of imlunestrant against the effects of food and omeprazole in the body. For each participant, the study may last up to 2.5 months and participants can expect to stay in the clinical research unit (CRU) up to 27 days over several visits.
Conditions
- Healthy
Interventions
Imlunestrant (Test)Drug
Administered orally
Imlunestrant (Reference)Drug
Administered orally
OmeprazoleDrug
Administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetics (PK): Maximum Concentration (Cmax) of Imlunestrant (Freebase)Time frame: Baseline, Up to Day 36
- 2. PK: Area Under the Concentration Versus Time Curve (AUC) of Imlunestrant (Freebase)Time frame: Baseline, Up to Day 36
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Qps-Mra, Llc
South Miami, Florida
ICON
Lenexa, Kansas
QPS Missouri
Springfield, Missouri
ICON Early Phase Services
San Antonio, Texas
ICON
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.